PACKAGE LEAFLET: INFORMATION FOR THE USER. Terbinafine Aurobindo 125 mg tablets Terbinafine Aurobindo 250 mg tablets (Terbinafine)

Size: px
Start display at page:

Download "PACKAGE LEAFLET: INFORMATION FOR THE USER. Terbinafine Aurobindo 125 mg tablets Terbinafine Aurobindo 250 mg tablets (Terbinafine)"

Transcription

1 PACKAGE LEAFLET: INFORMATION FOR THE USER Terbinafine Aurobindo 125 mg tablets Terbinafine Aurobindo 250 mg tablets (Terbinafine) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Terbinafine Aurobindo is and what it is used for 2. Before you use Terbinafine Aurobindo 3. How to use Terbinafine Aurobindo 4. Possible side effects 5. How to store Terbinafine Aurobindo 6. Further information 1. WHAT TERBINAFINE AUROBINDO IS AND WHAT IT IS USED FOR Terbinafine Aurobindo belongs to a group of medicines called antifungals. It is used for the treatment of fungal infections of the skin (including those in between the fingers and toes) and of the nails. 2. BEFORE YOU USE TERBINAFINE AUROBINDO Do not use Terbinafine Aurobindo if you are allergic (hypersensitivity) to terbinafine or any of the other ingredients of Terbinafine Aurobindo. if you have a severe kidney problem. if you have a severe liver problem Take special care with Terbinafine Aurobindo if you have liver problems or a disease which may affect your liver. if you have psoriasis (skin disease with raised red patches of skin covered with silvery scales). if you have kidney problems. develop severe reduction in the number of white blood cells which make infections more likely (agranulocytosis) or serious illness with blistering of the skin (toxic epidermal necrolysis). You should stop taking Terbinafine Aurobindo and see your doctor immediately if you experience these side effects which are known to occur very rarely (see section 4). If any of the above warnings applies to you or has applied to you in the past, consult your doctor. Taking other medicines Please tell to your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. the antibiotic, rifampicin (decreases the level of terbinafine in your blood).

2 cimetidine (a medicine for stomach ulcers and heartburn) increases the level of terbinafine in your blood. medicines used to treat depression such as clomipramine, lofepramine or paroxetine. certain medicines used to treat Parkinson s disease such as monoamine oxidase inhibitors e.g. selegiline. medicines used to treat high blood pressure or heart problems such as atenolol or carvedilol (beta blockers), oral contraceptives (the pill). Irregular periods and abnormal menstrual bleeding which may be between periods may occur in female patients. flecainide and propafenone, which are used to treat heart flutters (arrhythmias). ciclosporin (medicine used to prevent rejection of organs or tissues following a transplant or to treat certain skin conditions like psoriasis and eczema or to treat rheumatoid arthritis) tolbutamide for diabetes triazolam for relieving anxiety and/or trouble sleeping terfenadine for hay fever or other allergies Please note that the above medicines may be known to you by other names. Always thoroughly check the information leaflet of the medicines you are already using and check with your doctor or pharmacist before taking Terbinafine Aurobindo if you are taking any of the above sorts of medicines. Taking Terbinafine Aurobindo with food and drink Taking food and drink has no influence on terbinafine treatment. Pregnancy and breast-feeding If you are pregnant, think you are pregnant or are breast-feeding; you should not take Terbinafine Aurobindo unless your doctor tells you to. If you become pregnant whilst taking this medicine, you should tell your doctor as soon as possible. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Terbinafine Aurobindo should not affect your ability to drive or use machines. 3. HOW TO USE TERBINAFINE AUROBINDO Always take Terbinafine Aurobindo exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Dosage Adults: The dose you are prescribed will depend on the type of infection and how bad it is. The usual dose is 250 mg Terbinafine Aurobindo daily. You should swallow your tablet whole with a glass of water. The tablets can be taken with or without food. If you suffer from kidney problems, your doctor may prescribe half the recommended dose. Duration of treatment: Your doctor will tell you how long your treatment with terbinafine will last. For general fungal skin infections, your treatment will probably last for 4 weeks. Treatment for skin infections affecting the groin or body will normally last between 2 to 4 weeks and those involving feet may last between 2 to 6 weeks.

3 For nail infections your treatment may last between 6 weeks and 3 months, although treatment for toenail infections may continue for 6 months or longer. Complete resolution of the signs and symptoms of the infection may not occur until several weeks after treatment has stopped and the infection has been cured. Children and adolescents (below 18 years of age) Terbinafine is not recommended for children and adolescents under 18 years. If you take more Terbinafine Aurobindo than you should If you or someone you know has taken more tablets than they should, consult your doctor or the nearest hospital casualty department immediately. Take this leaflet or some tablets with you so your doctor will know what you have taken.you may feel dizzy, sick and have a headache and/or stomach pain. If you forget to take Terbinafine Aurobindo If you forget to take Terbinafine Aurobindo at the right time, take them as soon as you remember. Do not take a double dose to make up for a forgotten dose. If you stop taking Terbinafine Aurobindo Do not stop taking terbinafine without consultation with your doctor, even if the infection heals. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Terbinafine Aurobindo can cause side effects, although not everybody gets them. The following side effects have been observed: You should stop taking your tablets and see your doctor immediately if you experience symptoms of angioedema / anaphylaxis, such as: - swollen face, tongue or pharynx - difficulty in swallowing - hives - difficulties in breathing - feeling faint you experience skin reactions such as weals, blisters, or a progressive rash you have abnormalities of liver function. Symptoms include yellowing of the skin, itching, unexplained and persistent nausea (feeling sick), tiredness, vomiting (being sick), dark coloured urine, light coloured stools and abdominal (tummy) pain. Very common (more than 1 in 10 patients) Joint pain (arthralgia) and muscle pain (myalgia) can occur in association with allergic skin rashes. Rash, reddening of skin with itching and hives (urticaria). If progressive skin rash occurs, the treatment must be discontinued. Common (in more than 1 in 100 patients, but less than 1 in 10 patients): Headache. Loss of appetite Stomachache, feeling of fullness, diarrhoea indigestion (dyspepsia), feeling sick (nausea). Increased hepatic enzyme levels Uncommon (in more than 1 in 1,000 patients, but less than 1 in 100 patients):

4 Loss or decrease of the sense of taste (ageusia or dysgeusia), This usually resolves slowly once you have stopped taking the medicine. Very rare cases of prolonged taste disturbances have been reported, sometimes leading to a decrease of food intake and significant weight loss. Rare (in more than 1 in 10,000 patients, but less than 1 in 1,000 patients): Incidence of allergic reactions (including anaphylaxis). Pins and needles sensation (paraesthesias), numbness (hypesthesia) and dizziness. Abnormal liver function, including liver inflammation (hepatitis) and jaundice (yellowing of the skin and eyes). Tiredness (fatigue), vague illness (malaise). Very rare (in less than 1 in 10,000 patients, including isolated reports): Reductions in the number of different types of blood cells which may increase the risk of severe infection, bleeding or may cause shortness of breath and tiredness (agranulocytosis, neutropenia, thrombocytopenia, pancytopenia). A Condition which may cause a very wide variety of symptoms such as joint pain, kidney problems, rash and fever (systemic lupus erythematosus). Anxiety and depression. Stevens-Johnson syndrome (a serious illness with blistering of the skin, mouth, eyes and genitals), Hair loss. Toxic epidermal necrolysis (a serious illness with blistering and loss of the skin), Menstrual disturbance such as abnormal menstrual bleeding which may be between periods, and an irregular cycle. Sensation of dizziness (vertigo). Serious allergic reactions, which causes swelling of the face or throat (angio odema) Increased sensitivity of your skin to sunlight. Psoriasiform eruptions or exacerbation of psoriasis. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE TERBINAFINE AUROBINDO Keep out of the reach and sight of children. Do not use Terbinafine Aurobindo after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month. Store in the original package in order to protect from light. Medicines should not be disposed off via wastewater or household waste. Ask your pharmacist how to dispose off medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Terbinafine Aurobindo contains The active substance is terbinafine. Each tablet contains 125 mg of terbinafine (as terbinafine hydrochloride). Each tablet contains 250 mg of terbinafine (as terbinafine hydrochloride). The other ingredients are cellulose microcrystalline, sodium starch glycolate (type A), silica colloidal anhydrous, hypromellose and magnesium steararte. What Terbinafine Aurobindo looks like and contents of the pack

5 Tablets 125 mg: White to off-white, round uncoated, biconvex bevelled edge tablets having D debossed on one side and 56 on the other side. 250 mg: White to off-white, round uncoated, biconvex bevelled edge tablets with breakline and D debossed on one side and 74 on the other side. The tablet can be divided into equal halves. Terbinafine Aurobindo tablets are available in PVC/PVDC/Aluminum blister packs of 6, 7, 8, 10, 12, 14, 20, 28, 30, 42, 50, 56, 60, 84, 90, 98, 100, 250 and 500 tablets. Not all pack sizes may be marketed. Marketing Authorization Holder Manufacturer This medicinal product is authorised in the Member States of the EEA under the following names: France: Germany: Italy: Malta: Netherlands: Poland: Spain: United Kingdom: TERBINAFINE ARROW GENERIQUES 250 mg, comprimé sécable Terbinafin Aurobindo 125/ 250 mg Tabletten Terbinafina Aurobindo Pharma Italia 250 mg compresse Terbinafine Aurobindo 125 mg/ 250mg tablets Terbinafine Aurobindo 125/ 250 mg, tabletten Terbinafine Aurobindo Terbinafina Aurobindo 250 mg comprimidos Terbinafine 250 mg tablets This leaflet was last approved in {MM/YYYY}.

6 PACKAGE LEAFLET: INFORMATION FOR THE USER Terbinafine Aurobindo 125 mg tablets Terbinafine Aurobindo 250 mg tablets (Terbinafine) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Terbinafine Aurobindo is and what it is used for 2. Before you use Terbinafine Aurobindo 3. How to use Terbinafine Aurobindo 4. Possible side effects 5. How to store Terbinafine Aurobindo 6. Further information 1. WHAT TERBINAFINE AUROBINDO IS AND WHAT IT IS USED FOR Terbinafine Aurobindo belongs to a group of medicines called antifungals. It is used for the treatment of fungal infections of the skin (including those in between the fingers and toes) and of the nails. 2. BEFORE YOU USE TERBINAFINE AUROBINDO Do not use Terbinafine Aurobindo if you are allergic (hypersensitivity) to terbinafine or any of the other ingredients of Terbinafine Aurobindo. if you have a severe kidney problem. if you have a severe liver problem Take special care with Terbinafine Aurobindo if you have liver problems or a disease which may affect your liver. if you have psoriasis (skin disease with raised red patches of skin covered with silvery scales). if you have kidney problems. develop severe reduction in the number of white blood cells which make infections more likely (agranulocytosis) or serious illness with blistering of the skin (toxic epidermal necrolysis). You should stop taking Terbinafine Aurobindo and see your doctor immediately if you experience these side effects which are known to occur very rarely (see section 4). If any of the above warnings applies to you or has applied to you in the past, consult your doctor. Taking other medicines Please tell to your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. the antibiotic, rifampicin (decreases the level of terbinafine in your blood).

7 cimetidine (a medicine for stomach ulcers and heartburn) increases the level of terbinafine in your blood. medicines used to treat depression such as clomipramine, lofepramine or paroxetine. certain medicines used to treat Parkinson s disease such as monoamine oxidase inhibitors e.g. selegiline. medicines used to treat high blood pressure or heart problems such as atenolol or carvedilol (beta blockers), oral contraceptives (the pill). Irregular periods and abnormal menstrual bleeding which may be between periods may occur in female patients. flecainide and propafenone, which are used to treat heart flutters (arrhythmias). ciclosporin (medicine used to prevent rejection of organs or tissues following a transplant or to treat certain skin conditions like psoriasis and eczema or to treat rheumatoid arthritis) tolbutamide for diabetes triazolam for relieving anxiety and/or trouble sleeping terfenadine for hay fever or other allergies Please note that the above medicines may be known to you by other names. Always thoroughly check the information leaflet of the medicines you are already using and check with your doctor or pharmacist before taking Terbinafine Aurobindo if you are taking any of the above sorts of medicines. Taking Terbinafine Aurobindo with food and drink Taking food and drink has no influence on terbinafine treatment. Pregnancy and breast-feeding If you are pregnant, think you are pregnant or are breast-feeding; you should not take Terbinafine Aurobindo unless your doctor tells you to. If you become pregnant whilst taking this medicine, you should tell your doctor as soon as possible. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Terbinafine Aurobindo should not affect your ability to drive or use machines. 3. HOW TO USE TERBINAFINE AUROBINDO Always take Terbinafine Aurobindo exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Dosage Adults: The dose you are prescribed will depend on the type of infection and how bad it is. The usual dose is 250 mg Terbinafine Aurobindo daily. You should swallow your tablet whole with a glass of water. The tablets can be taken with or without food. If you suffer from kidney problems, your doctor may prescribe half the recommended dose. Duration of treatment: Your doctor will tell you how long your treatment with terbinafine will last. For general fungal skin infections, your treatment will probably last for 4 weeks. Treatment for skin infections affecting the groin or body will normally last between 2 to 4 weeks and those involving feet may last between 2 to 6 weeks.

8 For nail infections your treatment may last between 6 weeks and 3 months, although treatment for toenail infections may continue for 6 months or longer. Complete resolution of the signs and symptoms of the infection may not occur until several weeks after treatment has stopped and the infection has been cured. Children and adolescents (below 18 years of age) Terbinafine is not recommended for children and adolescents under 18 years. If you take more Terbinafine Aurobindo than you should If you or someone you know has taken more tablets than they should, consult your doctor or the nearest hospital casualty department immediately. Take this leaflet or some tablets with you so your doctor will know what you have taken.you may feel dizzy, sick and have a headache and/or stomach pain. If you forget to take Terbinafine Aurobindo If you forget to take Terbinafine Aurobindo at the right time, take them as soon as you remember. Do not take a double dose to make up for a forgotten dose. If you stop taking Terbinafine Aurobindo Do not stop taking terbinafine without consultation with your doctor, even if the infection heals. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Terbinafine Aurobindo can cause side effects, although not everybody gets them. The following side effects have been observed: You should stop taking your tablets and see your doctor immediately if you experience symptoms of angioedema / anaphylaxis, such as: - swollen face, tongue or pharynx - difficulty in swallowing - hives - difficulties in breathing - feeling faint you experience skin reactions such as weals, blisters, or a progressive rash you have abnormalities of liver function. Symptoms include yellowing of the skin, itching, unexplained and persistent nausea (feeling sick), tiredness, vomiting (being sick), dark coloured urine, light coloured stools and abdominal (tummy) pain. Very common (more than 1 in 10 patients) Joint pain (arthralgia) and muscle pain (myalgia) can occur in association with allergic skin rashes. Rash, reddening of skin with itching and hives (urticaria). If progressive skin rash occurs, the treatment must be discontinued. Common (in more than 1 in 100 patients, but less than 1 in 10 patients): Headache. Loss of appetite Stomachache, feeling of fullness, diarrhoea indigestion (dyspepsia), feeling sick (nausea). Increased hepatic enzyme levels Uncommon (in more than 1 in 1,000 patients, but less than 1 in 100 patients):

9 Loss or decrease of the sense of taste (ageusia or dysgeusia), This usually resolves slowly once you have stopped taking the medicine. Very rare cases of prolonged taste disturbances have been reported, sometimes leading to a decrease of food intake and significant weight loss. Rare (in more than 1 in 10,000 patients, but less than 1 in 1,000 patients): Incidence of allergic reactions (including anaphylaxis). Pins and needles sensation (paraesthesias), numbness (hypesthesia) and dizziness. Abnormal liver function, including liver inflammation (hepatitis) and jaundice (yellowing of the skin and eyes). Tiredness (fatigue), vague illness (malaise). Very rare (in less than 1 in 10,000 patients, including isolated reports): Reductions in the number of different types of blood cells which may increase the risk of severe infection, bleeding or may cause shortness of breath and tiredness (agranulocytosis, neutropenia, thrombocytopenia, pancytopenia). A Condition which may cause a very wide variety of symptoms such as joint pain, kidney problems, rash and fever (systemic lupus erythematosus). Anxiety and depression. Stevens-Johnson syndrome (a serious illness with blistering of the skin, mouth, eyes and genitals), Hair loss. Toxic epidermal necrolysis (a serious illness with blistering and loss of the skin), Menstrual disturbance such as abnormal menstrual bleeding which may be between periods, and an irregular cycle. Sensation of dizziness (vertigo). Serious allergic reactions, which causes swelling of the face or throat (angio odema) Increased sensitivity of your skin to sunlight. Psoriasiform eruptions or exacerbation of psoriasis. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE TERBINAFINE AUROBINDO Keep out of the reach and sight of children. Do not use Terbinafine Aurobindo after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month. Store in the original package in order to protect from light. Medicines should not be disposed off via wastewater or household waste. Ask your pharmacist how to dispose off medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Terbinafine Aurobindo contains The active substance is terbinafine. Each tablet contains 125 mg of terbinafine (as terbinafine hydrochloride). Each tablet contains 250 mg of terbinafine (as terbinafine hydrochloride). The other ingredients are cellulose microcrystalline, sodium starch glycolate (type A), silica colloidal anhydrous, hypromellose and magnesium steararte. What Terbinafine Aurobindo looks like and contents of the pack

10 Tablets 125 mg: White to off-white, round uncoated, biconvex bevelled edge tablets having D debossed on one side and 56 on the other side. 250 mg: White to off-white, round uncoated, biconvex bevelled edge tablets with breakline and D debossed on one side and 74 on the other side. The tablet can be divided into equal halves. Terbinafine Aurobindo tablets are available in PVC/PVDC/Aluminum blister packs of 6, 7, 8, 10, 12, 14, 20, 28, 30, 42, 50, 56, 60, 84, 90, 98, 100, 250 and 500 tablets. Not all pack sizes may be marketed. Marketing Authorization Holder Manufacturer This medicinal product is authorised in the Member States of the EEA under the following names: France: Germany: Italy: Malta: Netherlands: Poland: Spain: United Kingdom: Terbinafine Aurobindo 125/ 250 mg compriméterbinafine ARROW GENERIQUES 250 mg, comprimé sécable Terbinafin Aurobindo 125/ 250 mg Tabletten Terbinafina Aurobindo Pharma Italia 250 mg compresse Terbinafine Aurobindo 125 mg/ 250mg tablets Terbinafine Aurobindo 125/ 250 mg, tabletten Terbinafine Aurobindo Terbinafina Aurobindo 250 mg comprimidos Terbinafine 250 mg tablets This leaflet was last approved in {MM/YYYY}.

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because

More information

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Lovastatin Mylan 20 mg Tablets Lovastatin Mylan 40 mg Tablets lovastatin Read all of this leaflet carefully before you start taking this medicine.

More information

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin Package leaflet: Information for the user Dalmevin 50 mg tablets Vildagliptin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine Package leaflet: Information for the patient Histaclar 10 mg Film-coated Tablets loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Read all of this leaflet carefully before you start taking this medicine.

Read all of this leaflet carefully before you start taking this medicine. Package Leaflet: Information for the User Tamoxifen 10mg Tablets Tamoxifen Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If

More information

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You

More information

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium) Package leaflet: Information for the user Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine) Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg Tablets sodium fusidate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER Dear Patient! You have been prescribed Terbinafine "Genericon" 250 mg - tablets by your doctor, who, in the interests of improving your state of health, considers this product to be suitable for the treatment

More information

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin PATIENT INFORMATION LEAFLET ZITHROMAX 250mg Capsules azithromycin Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you have

More information

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

1. What Betahistine dihydrochloride tablets is and what it is used for

1. What Betahistine dihydrochloride tablets is and what it is used for Package leaflet: Information for the user Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains

More information

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride Read all of this leaflet carefully before you start using this

More information

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets Pizotifen (as malate) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine Package leaflet: Information for the patient [To be completed nationally] 10 mg film-coated tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) PACKAGE LEAFLET Package leaflet: Information for the user Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) Read all of this leaflet carefully before you start taking this medicine because

More information

Read all of this leaflet carefully before you start taking this medicine.

Read all of this leaflet carefully before you start taking this medicine. Moxelle 20mg Tablets Tamoxifen Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline Package leaflet: Information for the patient Lymelysal 300 mg hard capsules lymecycline equivalent to 300 mg tetracycline Read all of this leaflet carefully before you start taking this medicine because

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may

More information

XYZAL 5 MG FILM-COATED TABLET

XYZAL 5 MG FILM-COATED TABLET XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,

More information

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride) Package leaflet: Information for the patient Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride) Read all of this leaflet carefully before you start taking this medicine because

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER ARICEPT Evess 5 mg Orodispersible Tablets ARICEPT Evess 10 mg Orodispersible Tablets (Donepezil Hydrochloride) You and your caregiver should read all of this leaflet

More information

Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine

Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine Package leaflet: Information for the user Tetrabenazine 25 mg tablets tetrabenazine Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Pravat 40 mg tablets. Pravastatin sodium

Pravat 40 mg tablets. Pravastatin sodium Package leaflet: Information for the patient Pravat 10 mg tablets Pravat 20 mg tablets Pravat 40 mg tablets Pravastatin sodium Read all of this leaflet carefully before you start taking this medicine because

More information

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base) Package leaflet: Information for the user Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base) Read all of this leaflet carefully before you start taking this medicine because

More information

2 What you need to know before you take Zantac

2 What you need to know before you take Zantac Package leaflet: Information for the user Zantac Tablets 150 mg and 300 mg ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Anastrozole 1 mg film-coated tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir Package leaflet: Information for the user Famvir 125, 250 and 500 mg film-coated tablets famciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Cinacalcet Devatis 30 mg filmomhulde tabletten Cinacalcet Devatis 60 mg filmomhulde tabletten Cinacalcet Devatis 90 mg filmomhulde tabletten Cinacalcet Read

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ondansetron BMM Pharma 8 mg film-coated tablets. Ondansetron

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ondansetron BMM Pharma 8 mg film-coated tablets. Ondansetron PACKAGE LEAFLET: INFORMATION FOR THE USER Ondansetron BMM Pharma 4 mg film-coated tablets Ondansetron BMM Pharma 8 mg film-coated tablets Ondansetron Read all of this leaflet carefully before you start

More information

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET Tiorfix Tiorfast 100 mg PACKAGE LEAFLET 1 Tiorfix Tiorfast 100 mg Package leaflet: Information for the user 100 mg hard capsules Racecadotril Read all of this leaflet carefully before you start taking

More information

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the user. Fluvastatin Package leaflet: Information for the user Lescol XL 80 mg prolonged-release tablets Fluvastatin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

SULFASALAZIN 500mg enteric-coated tablets

SULFASALAZIN 500mg enteric-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SULFASALAZIN 500mg enteric-coated tablets SULFASALAZINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a

More information

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide) Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Package leaflet: Information for the user Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Irbesartan 75mg Film-coated Tablets Irbesartan 150mg Film-coated Tablets Irbesartan 300mg Film-coated Tablets irbesartan Read all of this leaflet carefully before

More information

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine Package leaflet: Information for the user Lorastad 10 mg Tablets loratadine [For medicines available only on prescription to be deleted if applicable:] Read all of this leaflet carefully before you start

More information

Package leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin

Package leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin Package leaflet: Information for the user Melatonin Pharma Nord 3 mg, film-coated tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You

More information

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine PACKAGE LEAFLET Package leaflet: Information for the user Ranitidin Actavis 150 mg and 300 mg film-coated tablets Ranitidine Read all of this leaflet carefully, before you start taking this medicine because

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan Dispersible 20/120 * Artemether/Lumefantrine 20mg/120mg Read all of this leaflet carefully before you

More information

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine)

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) PACKAGE LEAFLET INFORMATION FOR THE USER Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) Read all of this leaflet carefully before you start taking this medicine.

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Cefadroxil Mylan 500mg Capsules, hard Cefadroxil Mylan 1g Film-coated Tablets Cefadroxil Mylan 100mg/ml Powder for Oral Suspension Cefadroxil Read all of this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin HCl Ranbaxy 10 mg tablets, prolonged-release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before using this medicine. - Keep this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride) PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride) Read all of this leaflet carefully before you start taking this medicine. - Keep

More information

Package leaflet: information for the user

Package leaflet: information for the user Package leaflet: information for the user Valtrex 250 mg film-coated tablets Valtrex 500 mg film-coated tablets Valtrex 1000 mg film-coated tablets valaciclovir Read all of this leaflet carefully before

More information

Lochol XL 80 mg Prolonged-release Tablets

Lochol XL 80 mg Prolonged-release Tablets Package leaflet: Information for the user Lochol XL 80 mg Prolonged-release Tablets Fluvastatin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1 PACKAGE LEAFLET DIASTABOL 50 MG TABLETS 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Diastabol 50 mg tablets miglitol Read all of this leaflet carefully before you start taking this medicine. - Keep this

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.

More information

ATORIS 10, 20, 40 mg film-coated tablets

ATORIS 10, 20, 40 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER ATORIS 10, 20, 40 mg film-coated tablets ATORVASTATIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Package leaflet: Information for the patient Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Acetylsalicylic acid Read all of this leaflet carefully before you

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 35 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 35 mg film-coated tablets risedronate sodium PACKAGE LEAFLET: INFORMATION FOR THE USER Risedronat Jubilant 35 mg film-coated tablets risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole

Package leaflet: Information for the user. Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole Package leaflet: Information for the user Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium Package leaflet: Information for the patient Risedronate sodium 35 mg film-coated tablets Risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER 1 ethambutol hydrochloride Read all of this leaflet carefully before your child starts taking this medicine

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available

More information

Sibelium 5 mg Tablets flunarizine

Sibelium 5 mg Tablets flunarizine J-C 2017 Sibelium 5 mg Tablets flunarizine PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Package leaflet: Information for the user. Exemestane 25 mg coated tablets exemestane

Package leaflet: Information for the user. Exemestane 25 mg coated tablets exemestane Package leaflet: Information for the user Exemestane 25 mg coated tablets exemestane Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan Package leaflet: Information for the user Zomig 2.5 mg tablets zolmitriptan Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Package leaflet: Information for the patient Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 5 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 5 mg film-coated tablets risedronate sodium PACKAGE LEAFLET: INFORMATION FOR THE USER Risedronat Jubilant 5 mg film-coated tablets risedronate sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the patient. Valsartan 320 mg Film-coated Tablets valsartan

Package leaflet: Information for the patient. Valsartan 320 mg Film-coated Tablets valsartan Package leaflet: Information for the patient Valsartan 320 mg Film-coated Tablets valsartan Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information

More information

ALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa)

ALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa) PACKAGE LEAFLET: INFORMATION FOR THE USER ALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa) Read all of this leaflet carefully before you start taking this medicine because

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan 20/120 * artemether/lumefantrine 20mg/120mg tablets Read all of this leaflet carefully before you start

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets Lercanidipine hydrochloride Read all of this leaflet carefully before you start

More information

METHYLDOPA 250 mg Film-coated Tablets

METHYLDOPA 250 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin Package leaflet: Information for the user Floxapen 250 mg & 500 mg Capsules Flucloxacillin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine Package leaflet: Information for the patient Felodipin AstraZeneca 2.5 mg prolonged-release tablets Felodipin AstraZeneca 5 mg prolonged-release tablets Felodipin AstraZeneca 10 mg prolonged-release tablets

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine

More information

HERNOVIR 200 mg tablets

HERNOVIR 200 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

Package leaflet: Information for the patient. Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril)

Package leaflet: Information for the patient. Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril) Package leaflet: Information for the patient Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril) Read all of this leaflet carefully before you start taking this medicine

More information

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride PACKAGE LEAFLET 1 Package leaflet: Information for the user 5 mg film coated tablets Finasteride Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe Package leaflet: Information for the user Ezetimibe STADA 10 mg, tabletten Ezetimibe Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need

More information

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan Package leaflet: Information for the user 75 mg film-coated tablets 150 mg film-coated tablets 300 mg film-coated tablets irbesartan Read all of this leaflet carefully before you start taking this medicine

More information

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET. PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Pyrazinamide 500 mg Tablets * Pyrazinamide Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets Otezla 30 mg film-coated tablets Apremilast This medicine is subject to additional monitoring.

More information